Matrix metalloproteinases, MMPs

Matrix metalloproteinases are zinc-dependent endopeptidases that degrade extracellular matrix. 23 different MMPs have ben identified. They are activated by proteases. They are inhibited by tissue inhibitors of MMPs (TIMPs). A subset of MMPs remain membrane-bound (MT-MMPs). MMPs are likely to play a role in tumour invasiveness.

Immunohistochemical expression

In follicular thyroid neoplasms:

 

Synonym

Adenomatous goitre

Follicular adenoma

Minimally invasive follicular carcinoma

Widely invasive follicular carcinoma

MMP-1

collagenase 1

10/10

9/9

15/15

6/6

MMP-2

gelatinase A

0/10

1/19

12/15

5/6

MMP-7

matrilysin

0/10

0/19

12/15

5/6

MMP-9

gelatinase B

3/10

11/19

13/15

4/6

MT1-MMP

 

6/10

15/19

14/15

4/6

TIMP-2

 

1/10

5/19

8/15

5/6

 

MMP-2 may be a useful indicator of malignancy in adrenocortical tumours

 

Adrenocortical adenoma

1/502

 

Adrenocortical carcinoma

37/502

   
   
   

Adrenal endothelial and stromal cells also stain for MMP-2. Strong staining of adrenocortical carcinomas correlated with a poor prognosis2.

 

Diagnostic utility

Positivity for MMP-2 and MMP-7 may help to distinguish benign follicular adenomas from invasive carcinomas of the thyroid (including minimally invasive carcinomas).

Diagnosis of malignancy in adrenocortical tumours.

References

1 Cho Mar K, Eimoto T, Tateyama H, et al. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions. Histopathology 2006; 48:286-94

2 Volante M, Sperone P, Bollito E, et al. Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas. Mod Pathol 2006; 19:1563-9

This page last revised 6.1.2007.

©SMUHT/PW Bishop